申请人:Warner-Lambert Company
公开号:US04950675A1
公开(公告)日:1990-08-21
Certain trans-6,6'-[[(substituted)pyridin-3,5-diyl]-dialkane- and dialkene-diyl]bis [tetrahydro-4-hydroxypyran]-2-ones and the corresponding ring-opened acids derived therefrom are potent inhibitors of the enzyme 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG-CoA reductase) and are useful as hypocholesterolemic and hypolipidemic agents.
某些取代的吡啶-3,5-二基-二烷基和二烯基基团的trans-6,6'-[[(取代)吡啶-3,5-二基]-二烷基和二烯基二基]双[四氢-4-羟基吡喃]-2-酮及其相应的环开放酸是酶3-羟基-3-甲基-谷氨酰辅酶A还原酶(HMG-CoA还原酶)的有效抑制剂,并可用作降低胆固醇和血脂的药物。